Schnucks adds 300-plus generics to its discount list
ST. LOUIS Schnuck Markets last week added more than 300 commonly-prescribed generic drugs to its prescription savings program via several new offers including $4 generics for up to a 30-day supply, and $10 for a 90-day supply on medications to treat a variety of ailments including high blood pressure, arthritis, asthma, cholesterol, diabetes, and allergies, according to published reports.
“We have been strategizing for months on how we might offer savings significant enough to help offset rising costs and enhance the one-stop shopping experience for our customers,” said Schnucks vice president of pharmacy Michael Juergensmeyer. “Back in October, Schnucks became the first chain to offer customers a 21-day supply of any one of more than 50 generic oral antibiotics at no charge. We’ve been able to significantly strengthen the program by bringing many more medications in through our own distribution center. This has enabled us to cut supply chain costs and pass those savings on to our customers.”
If a customer’s insurance dictates a lower price than $4 for a 30-supply or $10 for a 90-day supply, the customer will receive the prescription at the lower price.
“We recognize that as a major pharmacy operation with multiple store locations, we are in a good position to make affordable medications more accessible to customers in all markets we serve,” Juergensmeyer said.”
FDA issues final approval for Perrigo’s generic Zyrtec
ALLEGAN, Mich. The Food and Drug Administration has given approval to Perrigo to manufacture and market cetirizine hydrochloride syrup in 1mg per milliliter strength.
The syrup, a generic version of McNeil Consumer Healthcare’s Zyrtec syrup, relieves symptoms of allergic rhinitis.
“This approval reflects both our strategy to be first to market with important products and the unique position of the company both in front of and behind the pharmacy counter,” Perrigo Chairman and chief executive officer Joseph Papa said.
Pfizer, which originally marketed Zyrtec, reported that it had sales of $1 billion in 2007. Pfizer lost U.S. exclusivity for Zyrtec in January, according to its annual report.
Nestea introduces green tea with higher antioxidant concentration
ATLANTA Iced Tea brand Nestea announced today the launch of its new Green Tea Citrus and Diet Green Tea Citrus products with 50 percent more antioxidants than before, as well as a brand new look.
The new varieties combine all-natural fruit flavors and the natural goodness of tea, largely in response to consumer health awareness. Both products now contain 50 percent more natural tea antioxidants, with 96 milligrams of flavonoid antioxidants per eight fluid ounce serving.
“As summer approaches, it is the perfect time to introduce products for consumers who want to quickly revitalize their day,” said Penny McIntyre, senior vice president and general manager of coffee and tea for Coca-Cola North America. “Nestea offers delicious, simple blends of tea and natural fruit flavors. Our new Green Tea Citrus products with even more antioxidants are great additions to our line of refreshing teas.”
The new packaging features dynamic graphics that call attention to the antioxidant content and all-natural fruit flavors. Nestea’s Iced Tea with Lemon and Diet Iced Tea with Lemon flavors come in 20 ounce and half-liter plastic bottle 12-packs. The Iced Tea with Lemon also comes in aluminum cans (regular and diet) and 2-liter plastic bottles (regular).